Literature DB >> 29281151

Quantitative intravoxel incoherent motion parameters derived from whole-tumor volume for assessing pathological complete response to neoadjuvant chemotherapy in locally advanced rectal cancer.

Qiaoyu Xu1, Yanyan Xu1, Hongliang Sun1, Queenie Chan2, Kaining Shi3, Aiping Song4, Wu Wang1.   

Abstract

BACKGROUND: Many locally advanced rectal cancer (LARC) patients can benefit from neoadjuvant chemotherapy (NACT), with some achieving a pathological complete response (pCR). However, there is limited research reporting on the value of intravoxel incoherent motion (IVIM) in monitoring pCR in patients with LARC.
PURPOSE: To identify whether IVIM parameters derived from whole-tumor volume (WTV) before and after NACT could accurately assess pCR in patients with LARC. STUDY TYPE: Prospective patient control study. POPULATION: Fifty-one patients with LARC before and after NACT, prior to surgery. FIELD STRENGTH/SEQUENCE: IVIM-diffusion imaging at 3T. ASSESSMENT: Apparent diffusion coefficient (ADC), slow diffusion coefficient (D), fast diffusion coefficient (D*), and perfusion-related diffusion fraction (f) values were obtained on diffusion-weighted magnetic resonance images (DW-MRI) using WTV methods and calculated using a biexponential model before and after NACT. STATISTICAL TESTS: DWI-derived ADC and IVIM-derived parameters and their percentage changes (ΔADC%, ΔD%, ΔD*%, and Δf%) were compared using independent-samples t-test and Mann-Whitney U-test between the pCR and non-pCR groups. The diagnostic performance of IVIM parameters and their percentage changes were evaluated using receiver operating characteristic curves.
RESULTS: Compared with the non-pCR group, the pCR group exhibited significantly lower pre-ADCmean (P = 0.003) and pre-D values (P = 0.024), and significantly higher post-f (P = 0.002), ΔADCmean % (P = 0.002), ΔD% (P = 0.001), and Δf% values (P = 0.017). Receiver operating characteristic curves showed that the pre-D value had the best specificity (95.12%) and accuracy (86.27%) in predicting the pCR status, and ΔD% had the highest area under the curve (0.832) in assessing the pCR response to NACT. DATA
CONCLUSIONS: The IVIM-derived D value is a promising tool in predicting the pCR status before therapy. The percentage changes in D values after therapy may help assess the pCR status prior to surgery. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2017.
© 2017 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  diffusion-weighted imaging; intravoxel incoherent motion; locally advanced rectal cancer; magnetic resonance imaging; neoadjuvant chemotherapy; pathological complete response

Mesh:

Year:  2017        PMID: 29281151     DOI: 10.1002/jmri.25931

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  13 in total

Review 1.  Comparison of percentage changes in quantitative diffusion parameters for assessing pathological complete response to neoadjuvant therapy in locally advanced rectal cancer: a meta-analysis.

Authors:  Kai Chen; Hua-Long She; Tao Wu; Fang Hu; Tao Li; Liang-Ping Luo
Journal:  Abdom Radiol (NY)       Date:  2020-09-25

Review 2.  Diffusion MRI of cancer: From low to high b-values.

Authors:  Lei Tang; Xiaohong Joe Zhou
Journal:  J Magn Reson Imaging       Date:  2018-10-12       Impact factor: 4.813

3.  Machine learning for prediction of chemoradiation therapy response in rectal cancer using pre-treatment and mid-radiation multi-parametric MRI.

Authors:  Liming Shi; Yang Zhang; Ke Nie; Xiaonan Sun; Tianye Niu; Ning Yue; Tiffany Kwong; Peter Chang; Daniel Chow; Jeon-Hor Chen; Min-Ying Su
Journal:  Magn Reson Imaging       Date:  2019-05-03       Impact factor: 2.546

4.  Comparison of Intravoxel incoherent motion imaging and multiecho dynamic contrast-based MRI in rectal cancer.

Authors:  Kine Mari Bakke; Endre Grøvik; Sebastian Meltzer; Anne Negård; Stein Harald Holmedal; Lars Tore G Mikalsen; Lars Gustav Lyckander; Anne H Ree; Kjell-Inge Gjesdal; Kathrine R Redalen; Atle Bjørnerud
Journal:  J Magn Reson Imaging       Date:  2019-04-04       Impact factor: 4.813

Review 5.  MRI Evaluation of Complete Response of Locally Advanced Rectal Cancer After Neoadjuvant Therapy: Current Status and Future Trends.

Authors:  Qiaoyu Xu; Yanyan Xu; Hongliang Sun; Tao Jiang; Sheng Xie; Bee Yen Ooi; Yi Ding
Journal:  Cancer Manag Res       Date:  2021-06-01       Impact factor: 3.989

6.  The Value of Whole-Tumor Histogram and Texture Analysis Using Intravoxel Incoherent Motion in Differentiating Pathologic Subtypes of Locally Advanced Gastric Cancer.

Authors:  Huan-Huan Li; Bo Sun; Cong Tan; Rong Li; Cai-Xia Fu; Robert Grimm; Hui Zhu; Wei-Jun Peng
Journal:  Front Oncol       Date:  2022-02-09       Impact factor: 6.244

7.  Could intravoxel incoherent motion diffusion-weighted magnetic resonance imaging be feasible and beneficial to the evaluation of gastrointestinal tumors histopathology and the therapeutic response?

Authors:  Hou-Dong Zuo; Xiao-Ming Zhang
Journal:  World J Radiol       Date:  2018-10-28

8.  Can the low and high b-value distribution influence the pseudodiffusion parameter derived from IVIM DWI in normal brain?

Authors:  Yu-Chuan Hu; Lin-Feng Yan; Yu Han; Shi-Jun Duan; Qian Sun; Gang-Feng Li; Wen Wang; Xiao-Cheng Wei; Dan-Dan Zheng; Guang-Bin Cui
Journal:  BMC Med Imaging       Date:  2020-02-10       Impact factor: 1.930

9.  Magnetic Resonance of Rectal Cancer Response to Therapy: An Image Quality Comparison between 3.0 and 1.5 Tesla.

Authors:  Damiano Caruso; Marta Zerunian; Domenico De Santis; Tommaso Biondi; Pasquale Paolantonio; Marco Rengo; Davide Bellini; Riccardo Ferrari; Maria Ciolina; Elena Lucertini; Michela Polici; Elsa Iannicelli; Vincenzo Tombolini; Andrea Laghi
Journal:  Biomed Res Int       Date:  2020-10-10       Impact factor: 3.411

10.  3.0 T MRI IVIM-DWI for predicting the efficacy of neoadjuvant chemoradiation for locally advanced rectal cancer.

Authors:  Hongbo Hu; Huijie Jiang; Song Wang; Hao Jiang; Sheng Zhao; Wenbin Pan
Journal:  Abdom Radiol (NY)       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.